Small Molecule

Esperion's innovative Lipid Management Team is committed to leveraging its understanding of cholesterol biosynthesis to develop convenient, complementary, consistent, once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein (LDL-C). Their goal is lipid management for everybody, that’s why they work hard to make medicines accessible. They discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Positions are location-specific.